Purchase Order HT942524P0033
Award Date 2/23/24
Potential Completion Date 9/22/24
Potential Value $250K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Alachua, FL 32615, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
4
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
STTR Phase I
Primary Consortia Member
Not listed Similar Awards
- This is a $1,299,972.00 firm-fixed-price definitive contract awarded by the Defense Health Agency (DHA) to Fabrico Technology, Inc., a minority-owned and Asian-Pacific American-owned small business, under the Small Business Technology Transfer (STTR) Phase II program. The contract is for the "Development of Antibody Treatment of MDR ESKAPE Pathogen, P. Aeruginosa," which involves medical research and development related to chemical and biological defense, antibody treatments, and...
- The Defense Health Agency awarded a $1.86M firm-fixed-price delivery order to Eitr Biologics, Inc. on September 20, 2024, for novel nanotherapeutics development. The San Diego-based biotechnology company will perform work through December 31, 2025. This delivery order is issued under Eitr Biologics' existing Indefinite Delivery Vehicle (IDV) contract with the Defense Health Agency, valued at $4.39M through August 2028, which focuses specifically on developing novel nanotherapeutics to combat...
- The U.S. Defense Health Agency (DHA) awarded a $250,000 Small Business Technology Transfer (STTR) Phase I contract to Zymeron Corporation, a minority-owned biotechnology company. The contract is for an "Automated Blood-In, miRNAs-Out Assay to Detect Circulating and Exosome miRNAs" to support DHA's biomedical research and development efforts. This STTR award is focused on early-stage research and development of innovative technologies aligned with the DHA's mission to provide healthcare...
- This federal contract award was issued by the Defense Health Agency (DHA) to Charlot Biosciences Inc., a minority-owned, small disadvantaged business, for a Phase I Small Business Innovation Research (SBIR) project titled "Rapid Detection of Bacteriophage Susceptibility in Antibiotic-Resistant Pathogens Using Cellphoresis". The firm-fixed-price purchase order has a potential value of $249,534.00 and a completion date of September 7, 2021. The contract is set aside for small...
- <p>This is a $224,589.00 firm fixed-price Definitive Contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Ecmedical LLC, a for-profit organization, under the Small Business Technology Transfer (STTR) program. The contract was awarded on March 18, 2019 and has a completion date of January 17, 2020. The contract is for STTR Phase I research, which is a set-aside for small businesses. The place of performance is Irwin, PA 15642, USA.</p>
- The Defense Health Agency awarded a $1.1M Small Business Technology Transfer Phase II contract to CFD Research Corporation for the development of portable phage preparation technology for field application under proposal number A2-9480. The contract, awarded July 3, 2023, with a completion date of May 2, 2026, is structured as a firm fixed-price definitive contract. As a designated small business set-aside award, this STTR Phase II effort builds upon earlier research to advance bacteriophage...
- This is a Definitive Contract awarded by the U.S. Army Medical Command (MEDCOM) to Emergent Travel Health Inc., a small business prime contractor. The $1,000,000.00 SBIR Phase II contract was awarded on September 21, 2015 for a Small Business Technology Transfer (STTR) research project. The contract supports the development of an infectious disease vaccine, with work being performed at the contractor's facility in Redwood City, California. Emergent Travel Health Inc. has previously provided...
- This federal contract award was issued by the Defense Health Agency (DHA) to Hybrid Plastics, Incorporated, a for-profit manufacturer, under the Small Business Innovation Research (SBIR) Program Phase II. The contract, valued at $999,997.59, is for the development of a "Hemostatic Agent" under the DHA PHASE II SBIR H2-0265 project. The contract is a Definitive Contract with a Cost Plus Fixed Fee pricing type, and the period of performance is from the award date of September 15, 2017...
- This is a federal contract award from the U.S. Army Medical Command (MEDCOM) to Starix Technology, Inc., a small business contractor, under the Small Business Innovation Research (SBIR) program. The contract, valued at $999,170.00, is for a Phase II SBIR project with a completion date of February 28, 2018. The contract is a Definitive Contract with a Fixed Price Level of Effort pricing type. As this is a set-aside for small businesses, Starix Technology, Inc. is the prime contractor and there...
- This is a $2,999,999.61 Firm Fixed Price Definitive Contract awarded by the Defense Health Agency, a defense agency, to Nushores Biosciences LLC, a small business, under the Small Business Innovation Research (SBIR) Program Phase II. The contract is for the development of a catalytically active device that removes ethylene oxide (ETO) used in sterilization processes. The contract has an ultimate completion date of January 19, 2027. This contract award is based on a previous SBIR Phase I grant...